Zeo ScientifiX (ZEOX) Cash & Current Investments (2013 - 2026)
Zeo ScientifiX (ZEOX) posted quarterly Cash & Current Investments of $1.8 million for Q2 2026, up 240.59% year-over-year from $542000.0 in Q2 2025, and up 79.22% quarter-over-quarter from $1.0 million in Q1 2026.
Zeo ScientifiX (ZEOX) Cash & Current Investments (2013 - 2026) Analysis & Trends
Zeo ScientifiX's Cash & Current Investments history runs 14 years deep, the most recent figure standing at $1.8 million for Q2 2026.
- In Q2 2026, Cash & Current Investments rose 240.59% year-over-year to $1.8 million; the TTM figure through Apr 2026 stood at $1.8 million (up 240.59% YoY), while the FY2025 annual figure was $221000.0, down 66.36% from the prior year.
- Cash & Current Investments for Q2 2026 stood at $1.8 million, up from $1.0 million in the prior quarter.
- The five-year high for Cash & Current Investments was $3.8 million in Q4 2022, with the low at $66002.0 in Q2 2022.
- The 5-year median for Cash & Current Investments is $733000.0 (2024), against an average of $959721.5.
- The sharpest annual moves came in 2022 and 2025: Cash & Current Investments surged 3356.76% in 2022, then slumped 77.38% in 2025.
- Zeo ScientifiX's Cash & Current Investments stood at $3.8 million in 2022, then sank by 53.21% to $1.8 million in 2023, then slumped by 62.59% to $657000.0 in 2024, then plunged by 66.36% to $221000.0 in 2025, then surged by 735.29% to $1.8 million in 2026.
- Business Quant data shows ZEOX's Cash & Current Investments at $1.8 million in Q2 2026, $1.0 million in Q1 2026, and $221000.0 in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 7.99 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 5.18 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 5.14 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 5.10 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 3.31 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 18.39 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 1.16 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 836.99 Mn |
| 10 | Zeo ScientifiX | 10.51 Mn | 8.67 Mn | 2.06 Mn | 1.85 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 1.85 Mn |
| Jan 31, 2026 | 1.03 Mn |
| Oct 31, 2025 | 221,000.00 |
| Jul 31, 2025 | 250,000.00 |
| Apr 30, 2025 | 542,000.00 |
| Jan 31, 2025 | 720,000.00 |
| Oct 31, 2024 | 657,000.00 |
| Jul 31, 2024 | 1.11 Mn |
| Apr 30, 2024 | 746,000.00 |
| Jan 31, 2024 | 1.17 Mn |
| Oct 31, 2023 | 1.76 Mn |
| Jul 31, 2023 | 633,000.00 |
| Apr 30, 2023 | 1.13 Mn |
| Jan 31, 2023 | 1.42 Mn |
| Oct 31, 2022 | 3.75 Mn |
| Jul 31, 2022 | 74,665.00 |
| Apr 30, 2022 | 66,002.00 |
| Jan 31, 2022 | 150,320.00 |
| Oct 31, 2021 | 108,570.00 |
| Jul 31, 2021 | 29,207.00 |